Apriem Advisors’s Eastman Chemical EMN Stock Holding History

Apriem Advisors’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-83	Closed	-$7K	–	253
2017 Q1	$7K	Hold	83	–	–	﹤0.01%	444
2016 Q4	$6K	Buy	+83	New	+$5.99K	﹤0.01%	478

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Apriem Advisors's EMN Position: Q2 2017 in Review

Apriem Advisors sold out of Eastman Chemical (EMN) in Q2 2017, closing a stake of 83 shares — an estimated $7K sold.

Apriem Advisors first reported a position in EMN in Q4 2016 and held it in 2 quarters. The position peaked at $7K in Q1 2017. 618 funds tracked by Wall St. Rank hold EMN as of Q2 2017.

Apriem Advisors reported no remaining Eastman Chemical position as of Q2 2017 after selling out during the quarter.
Apriem Advisors sold 83 Eastman Chemical shares in Q2 2017, an estimated $7K.
Apriem Advisors first reported a position in Eastman Chemical in Q4 2016 and held it in 2 quarters.
Apriem Advisors's Eastman Chemical position peaked at $7K in Q1 2017.
618 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2017.

Based on Apriem Advisors's 13F filing for Q2 2017, filed 4 Aug 2017.